Sobi
Organisation
Trials
Collaborator, Phase 2, Recruiting, 66 people, 24 Jun 2025
Collaborator, Phase 2, Recruiting, 39 people, 28 Mar 2023
Named in competing interests
Fees or honoraria, 28 Sept 2026
Consulting or advice, Board or leadership role, 22 Sept 2026
Consulting or advice, Fees or honoraria, Board or leadership role, 19 Sept 2026
Consulting or advice, Fees or honoraria, Grants or research support, 18 Sept 2026
Consulting or advice, Fees or honoraria, Grants or research support, 3 Sept 2026
Frailty assessment in people with hemophilia
Consulting or advice, Fees or honoraria, 31 Aug 2026
Consulting or advice, Fees or honoraria, Grants or research support, 29 Aug 2026
Fees or honoraria, 14 Aug 2026
Consulting or advice, 11 Aug 2026
Clonal dynamics on the road to hematological malignancy (MBL, MGUS, CH)
Fees or honoraria, 9 Aug 2026
Increased VWF-to-ADAMTS13 ratio is associated with large cerebral white matter hyperintensities
Consulting or advice, Fees or honoraria, Board or leadership role, 1 Jul 2026
Bempedoic Acid: From Guidelines to the Real World
Consulting or advice, Fees or honoraria, 4 May 2026
Disordered differentiation and cellular senescence in pediatric Hodgkin Reed-Sternberg cells
Consulting or advice, Board or leadership role, 28 Apr 2026
More than Glucose Elimination: Additional Benefits of SGLT2 Inhibitors in Glomerular Diseases
Consulting or advice, Fees or honoraria, Grants or research support, 15 Feb 2026
Consulting or advice, Board or leadership role, 1 Nov 2025
Epigenetic Aging Signatures in People with Hemophilia
Consulting or advice, Fees or honoraria, Board or leadership role, 23 Oct 2025
Sources: pubmed.ncbi.nlm.nih.gov